These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8629563)

  • 1. The minimally abnormal Papanicolaou smear.
    Brotzman GL; Julian TM
    Am Fam Physician; 1996 Mar; 53(4):1154-62. PubMed ID: 8629563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
    Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF
    J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
    Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
    Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
    Alanen KW; Elit LM; Molinaro PA; McLachlin CM
    Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bethesda system for the reporting of cervical/vaginal cytology.
    Oren A; Fernandes J
    J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of the AGUS Papanicolaou smear.
    Kaferle JE; Malouin JM
    Am Fam Physician; 2001 Jun; 63(11):2239-44. PubMed ID: 11417776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
    Howell LP; Davis RL
    Diagn Cytopathol; 1996 Feb; 14(1):20-4. PubMed ID: 8834072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperchromatic crowded groups: pitfalls in pap smear diagnosis.
    Demay RM
    Am J Clin Pathol; 2000 Nov; 114 Suppl():S36-43. PubMed ID: 11996167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information, discrimination and divergence in cytology. III. Optimization of classification of Papanicolaou smears.
    Okagaki T; Fujimura M; Zelterman D
    Acta Cytol; 1991; 35(1):30-4. PubMed ID: 1994631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bethesda system and evaluation of abnormal pap smears.
    Nguyen HN; Nordqvist SR
    Semin Surg Oncol; 1999; 16(3):217-21. PubMed ID: 10225298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the three most common Papanicolaou smear collection techniques.
    Germain M; Heaton R; Erickson D; Henry M; Nash J; O'Connor D
    Obstet Gynecol; 1994 Aug; 84(2):168-73. PubMed ID: 8041524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic conization of the uterine cervix. I. Classification of histological diagnoses].
    Geissler U
    Zentralbl Gynakol; 1977; 99(17):1025-7. PubMed ID: 919876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minimally abnormal Pap smear. A conservative approach.
    Zuber TJ
    Am Fam Physician; 1996 Mar; 53(4):1042, 1048, 1050 passim. PubMed ID: 8629553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytological classification of precancer and cancer of the cervix uteri].
    Agamova KA; Nikitina NI; Gosh TE; Tikhomirova EE; Gladunova ZD
    Vopr Onkol; 1987; 33(5):54-9. PubMed ID: 3590668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses.
    Kinney WK; Manos MM; Hurley LB; Ransley JE
    Obstet Gynecol; 1998 Jun; 91(6):973-6. PubMed ID: 9611007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.